Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 25
Filter
1.
Biotechnol Prog ; 33(6): 1508-1519, 2017 11.
Article in English | MEDLINE | ID: mdl-28840658

ABSTRACT

Haemophilus influenzae type b (Hib), a Gram-negative capsulated bacterium, is a causative agent of meningitis worldwide. The capsular polysaccharide, a high molecular mass polymer consisting of the repeated units of the polyribosyl-ribitol-phosphate, is considered the main virulence factor and it is used as an antigen to vaccines, conjugated to a carrier protein. The industrial production of the polysaccharide requires the cultivation of Hib in rich medium, which impacts process costs and product recovery. In this study, a central composite rotational experimental design strategy was used to access the influence of key components of culture medium (soy peptone, yeast extract and glucose) on biomass formation and polysaccharide production in shake-flasks. The optimized medium formulation, containing half of the usual yeast extract and soytone concentrations, was further validated in batch bioreactor cultivations. High polysaccharide production (∼500 mg/L) was obtained in a cheaper and more competitive production process for use in Hib vaccine production. In addition, simulations of a metabolic model describing Hib central metabolism were used to assess the role of key amino acids on growth. A chemically defined medium supplemented only with amino acids from α-ketoglutarate and oxaloacetate families as well as phenylalanine was suggested as a promising alternative for reduced acetate accumulation and enhanced polysaccharide production in Hib cultures. © 2017 American Institute of Chemical Engineers Biotechnol. Prog., 33:1508-1519, 2017.


Subject(s)
Cell Culture Techniques/methods , Haemophilus Vaccines/biosynthesis , Haemophilus influenzae type b/growth & development , Polysaccharides/metabolism , Bacterial Capsules/genetics , Bacterial Capsules/metabolism , Bioreactors , Culture Media , Haemophilus Vaccines/genetics , Haemophilus Vaccines/metabolism , Haemophilus Vaccines/therapeutic use , Haemophilus influenzae type b/pathogenicity , Humans , Meningitis/microbiology , Meningitis/prevention & control , Metabolic Flux Analysis , Polysaccharides/genetics , Polysaccharides/immunology
2.
Annu Rev Biochem ; 85: 599-630, 2016 Jun 02.
Article in English | MEDLINE | ID: mdl-27145845

ABSTRACT

Glycoscience research has been significantly impeded by the complex compositions of the glycans present in biological molecules and the lack of convenient tools suitable for studying the glycosylation process and its function. Polysaccharides and glycoconjugates are not encoded directly by genes; instead, their biosynthesis relies on the differential expression of carbohydrate enzymes, resulting in heterogeneous mixtures of glycoforms, each with a distinct physiological activity. Access to well-defined structures is required for functional study, and this has been provided by chemical and enzymatic synthesis and by the engineering of glycosylation pathways. This review covers general methods for preparing glycans commonly found in mammalian systems and applying them to the synthesis of therapeutically significant glycoconjugates (glycosaminoglycans, glycoproteins, glycolipids, glycosylphosphatidylinositol-anchored proteins) and the development of carbohydrate-based vaccines.


Subject(s)
Glycoconjugates/chemical synthesis , Glycoproteins/chemical synthesis , Glycosaminoglycans/chemical synthesis , Haemophilus Infections/prevention & control , Haemophilus Vaccines/administration & dosage , Polysaccharides/chemical synthesis , Amino Acid Sequence , Carbohydrate Conformation , Carbohydrate Sequence , Glycoconjugates/immunology , Glycolipids/chemical synthesis , Glycolipids/immunology , Glycoproteins/immunology , Glycosaminoglycans/immunology , Glycosylation , Glycosylphosphatidylinositols/chemical synthesis , Glycosylphosphatidylinositols/immunology , Haemophilus Infections/immunology , Haemophilus Infections/microbiology , Haemophilus Vaccines/chemical synthesis , Haemophilus influenzae type b/drug effects , Haemophilus influenzae type b/growth & development , Haemophilus influenzae type b/pathogenicity , Humans , Polysaccharides/immunology
3.
Appl Biochem Biotechnol ; 167(7): 2068-75, 2012 Aug.
Article in English | MEDLINE | ID: mdl-22665219

ABSTRACT

Capsular polysaccharide produced by Haemophilus influenzae b (Hib) is the main virulent agent and used as the antigen in the vaccine formulation. In this study, an improved process of polysaccharide purification was established based on tangential flow ultrafiltration using detergents (cocamidopropyl betaine and sodium deoxycholate), two selective ethanol precipitations steps, and extensive enzymatic hydrolysis as strategy. The relative purity (RP) related to protein and nucleic acids were 122~263 and 294~480, respectively, and compatible with the specifications established by the World Health Organization for Hib vaccine, RP≥100. These results make this process simple, cheaper, efficient, environmentally friendly, and prone to be scaled up.


Subject(s)
Bacterial Capsules/isolation & purification , Haemophilus influenzae type b/metabolism , Ultrafiltration/methods , Bacterial Capsules/biosynthesis , Glucose/pharmacology , Haemophilus influenzae type b/drug effects , Haemophilus influenzae type b/growth & development
4.
Kansenshogaku Zasshi ; 86(2): 103-8, 2012 Mar.
Article in Japanese | MEDLINE | ID: mdl-22606876

ABSTRACT

Haemophilus influenzae type b (Hib) remains the leading cause of invasive bacterial infection in Japanese children. More than 110 countries that have included Hib conjugate vaccines in their routine vaccination programs have seen dramatical decrease in the incidence of Hib infections. In Japan, the vaccine has been introduced for voluntary immunization since December 2008 and has been provided free of charge only since January 2011. This review reports the prevalence of Hib and its clones among healthy children and pediatric patients diagnosed with invasive or non-invasive Hib infections in Sado Island, Japan. Of 25 Hib isolates collected in this surveillance, 4 genotypic patterns (ST54-gBLPACR-III, ST54-gBLNAR-I/II, ST190-gBLNAS, and ST95-gBLPACR-I/II) were detected. These STs were double or triple-locus variants of each other. Under the same antimicrobial selective pressure, high prevalence of gBLPACR strain (76.0%) was confirmed in Hib isolates, while gBLPACR prevalence in nontypeable H. influenzae was very low (5.2%). These data suggested that each ST strain may be brought into Sado Island by different routes. We note that surveillance of healthy subjects to identify Hib carriers is important to understand their role in transmission of Hib.


Subject(s)
Haemophilus Infections/transmission , Haemophilus influenzae type b/growth & development , Child , Haemophilus influenzae type b/isolation & purification , Humans
5.
Can J Microbiol ; 54(4): 281-90, 2008 Apr.
Article in English | MEDLINE | ID: mdl-18389000

ABSTRACT

The structures of lipopolysaccharides (LPSs) of lic1 and lic1/lic2 mutants from Haemophilus influenzae type b strain Eagan (RM153) were investigated using methylation analysis, electrospray ionization - mass spectrometry, and nuclear magnetic resonance spectroscopy on O-deacylated, O- and N-deacylated core oligosaccharide (OS); and deacylated, dephosphorylated, and terminally reduced samples. The backbone OS derived from the major LPS glycoforms were determined to consist of the inner-core triheptosyl unit, L-alpha-D-Hepp-(1-2)-L-alpha-D-Hepp-(1-3)-L-alpha-D-Hepp-(1-, common to all H. influenzae strains investigated to date that is linked to the lipid A region of the molecule via a Kdo residue to which beta-D-Glcp and beta-D-Galp residues are attached in 1,4 and 1,2 linkages to the proximal (HepI) and distal (HepIII) heptose residues, respectively. It was found that the lic1 mutant predominately elaborates the Hex4 LPS glycoforms previously identified in the parent strain where a beta-D-Glcp-(1-4)-alpha-D-Glcp unit is linked in a 1,3 linkage to the central heptose (HepII) of the triheptosyl moiety. The lic1 locus consists of 4 genes (lic1A to lic1D) in a single transcriptional unit that directs phase variable expression of phosphocholine. The lic1A gene is phased off in the RM153 isolate of strain Eagan. LPS from the double mutant, lic1/lic2 had a similar structure to that of lic1 mutant except that there was no chain extension from the central heptose in the inner core (HepII). The lic2 locus consists of 4 genes (lic2A to lic2D). Our structural data were consistent with the proposed function of lic2C, providing the first definitive evidence for its role as the glycosyltransferase required for chain initiation from HepII. The presence of an O-acetyl group at O-3 of the distal heptose (HepIII) was elucidated by 1H NMR on the mild acid liberated core OS samples.


Subject(s)
Bacterial Proteins/genetics , Haemophilus influenzae type b/metabolism , Lipopolysaccharides/chemistry , Mutation , Oligosaccharides/chemistry , Carbohydrate Sequence , Haemophilus influenzae type b/chemistry , Haemophilus influenzae type b/genetics , Haemophilus influenzae type b/growth & development , Lipopolysaccharides/biosynthesis , Magnetic Resonance Spectroscopy , Molecular Structure , Oligosaccharides/biosynthesis , Spectrometry, Mass, Electrospray Ionization
6.
J Infect Dis ; 196(7): 1068-75, 2007 Oct 01.
Article in English | MEDLINE | ID: mdl-17763330

ABSTRACT

BACKGROUND: Many bacteria responsible for clinically relevant disease reside harmlessly in a large fraction of humans. Three explanations have been proposed to account for why these normally commensal bacteria occasionally cause invasive disease: host susceptibility, stochasticity in the host-bacteria interaction, and the evolution of invasive mutants in colonized hosts. Here we test the third of these hypotheses for the rare invasiveness of commensal bacteria: within-host evolution. METHODS AND RESULTS: Using neonatal rats intranasally colonized with pairs of marked Haemophilus influenzae type b strains, we demonstrate that the resulting bacteremias are derived from single organisms. To test the within-host evolution hypothesis we explored the relative ability of bacteria isolated from the blood and nasal passages of bacteremic rats to colonize the nasopharynx and invade the bloodstream. CONCLUSIONS: Our results provide support for within-host evolution as one but not the sole explanation for the invasiveness of these bacteria. We discuss the implications of these results for both the rare invasiveness of commensal bacteria and the general observation that bacteria isolated from the sites of human invasive disease are almost invariably monoclonal.


Subject(s)
Bacteremia/microbiology , Carrier State/microbiology , Evolution, Molecular , Haemophilus influenzae type b/genetics , Haemophilus influenzae type b/pathogenicity , Nasopharynx/microbiology , Animals , Animals, Newborn , Blood/microbiology , Haemophilus Infections/microbiology , Haemophilus influenzae type b/growth & development , Haemophilus influenzae type b/isolation & purification , Humans , Models, Biological , Rats
7.
Vaccine ; 25(1): 194-200, 2007 Jan 02.
Article in English | MEDLINE | ID: mdl-17161239

ABSTRACT

The relationships among physico-chemical and biological tests were evaluated in this study for Cuban Hib vaccine, a tetanus toxoid conjugated with a polysaccharide obtained from chemical synthesis, in order to estimate the biological significance of the relevant physico-chemical assays for lot released. In order to get samples with theoretical different potencies, Hib-TT samples were stored at -20, 4, 25, 37 and 70 degrees C for 5 weeks and after they were evaluated by HPLC and Orcinol methods and for immunogenicity and bactericidal activity. We found strong relationships between HPLC and free PRP level (r2=0.9571), anti-PRP antibodies and bactericidal activity (r2=0.9649) and free PRP content and anti-PRP antibodies titres (r2=0.7671). A lower correlation was found for HPLC and anti-PRP titres (r2=0.5996). We demonstrate that it is possible to monitor this new product combining physico-chemical and biological tests in order to contribute to its characterisation.


Subject(s)
Haemophilus Vaccines , Tetanus Toxoid , Vaccines, Conjugate , Animals , Antibodies, Bacterial/blood , Chromatography, High Pressure Liquid , Colony Count, Microbial , Drug Stability , Female , Haemophilus Vaccines/administration & dosage , Haemophilus Vaccines/chemistry , Haemophilus Vaccines/immunology , Haemophilus influenzae type b/drug effects , Haemophilus influenzae type b/growth & development , Haemophilus influenzae type b/immunology , Humans , Immunization , Immunoglobulin G/blood , Polysaccharides, Bacterial/immunology , Rabbits , Specimen Handling/methods , Temperature , Tetanus Toxoid/administration & dosage , Tetanus Toxoid/chemistry , Tetanus Toxoid/immunology , Vaccines, Conjugate/administration & dosage , Vaccines, Conjugate/chemistry , Vaccines, Conjugate/immunology
8.
J Immunol ; 177(1): 430-6, 2006 Jul 01.
Article in English | MEDLINE | ID: mdl-16785539

ABSTRACT

Vitronectin inhibits the membrane attack complex of the complement system and is found both in plasma and the extracellular matrix. In this study, we have identified the outer membrane protein Haemophilus surface fibrils (Hsf) as the major vitronectin-binding protein in encapsulated H. influenzae type b. A H. influenzae mutant devoid of Hsf showed a significantly decreased binding to both soluble and immobilized vitronectin as compared with the wild-type counterpart. Moreover, Escherichia coli-expressing Hsf at the surface strongly adhered to immobilized vitronectin. Importantly, the H. influenzae Hsf mutant had a markedly reduced survival as compared with the wild-type bacterium when incubated with normal human serum. A series of truncated Hsf fragments were recombinantly manufactured in E. coli. The vitronectin binding regions were located within two separate binding domains. In conclusion, Hsf interacts with vitronectin and thereby inhibits the complement-mediated bactericidal activity, and thus is a major H. influenzae virulence factor.


Subject(s)
Adhesins, Bacterial/physiology , Blood Bactericidal Activity/immunology , Haemophilus influenzae type b/immunology , Vitronectin/metabolism , Adhesins, Bacterial/genetics , Adhesins, Bacterial/metabolism , Amino Acid Sequence , Binding, Competitive/immunology , Blood Bactericidal Activity/genetics , Complement Membrane Attack Complex/antagonists & inhibitors , Complement Membrane Attack Complex/physiology , Dose-Response Relationship, Immunologic , Haemophilus influenzae type b/genetics , Haemophilus influenzae type b/growth & development , Haemophilus influenzae type b/pathogenicity , Heparin/metabolism , Heparin/physiology , Humans , Molecular Sequence Data , Mutagenesis, Insertional , Peptide Fragments/genetics , Peptide Fragments/metabolism , Peptide Fragments/physiology , Protein Binding/immunology , Protein Structure, Tertiary , Serum/immunology , Serum/microbiology , Virulence Factors/genetics , Virulence Factors/metabolism , Virulence Factors/physiology , Vitronectin/antagonists & inhibitors
9.
FEMS Immunol Med Microbiol ; 46(3): 426-32, 2006 Apr.
Article in English | MEDLINE | ID: mdl-16553817

ABSTRACT

Haemophilus influenzae has an absolute requirement for heme, which may be supplied as the haemoglobin-haptoglobin complex. Utilization of haemoglobin-haptoglobin by H. influenzae is mediated by a family of proteins termed the haemoglobin-haptoglobin binding proteins (Hgps), of which a given strain may contain up to four genes. Human haptoglobin occurs in three phenotypes (1-1, 2-1 and 2-2). Using mutant derivatives of an H. influenzae type b strain that expressed single Hgps we analysed the ability of each Hgp to utilize haemoglobin complexed to the various haptoglobin phenotypes. A strain expressing only HgpB was able to utilize haemoglobin bound to all haptoglobin phenotypes significantly better than strains expressing either HgpA or HgpC.


Subject(s)
Haemophilus Infections/microbiology , Haemophilus influenzae type b/growth & development , Haptoglobins/metabolism , Hemoglobins/metabolism , Bacterial Proteins/metabolism , Carrier Proteins/metabolism , Haemophilus Infections/virology , Haemophilus influenzae type b/metabolism , Humans , Phenotype , Statistics, Nonparametric
10.
Am J Trop Med Hyg ; 74(3): 509-15, 2006 Mar.
Article in English | MEDLINE | ID: mdl-16525115

ABSTRACT

From March 2000 to February 2002, a population-based study of Haemophilus influenzae type b (Hib) meningitis was conducted among children less than five years of age in Hanoi, Vietnam. Children with suspected bacterial meningitis were referred to hospitals and each patient underwent standardized clinical examination and microbiologic testing. In Hanoi, 580 children were evaluated for bacterial meningitis and 23 (4%) had confirmed or probable Hib meningitis. The incidence of all Hib meningitis was 12/100,000 child-years less than five years of age and 26/100,000 child-years less than two years of age. Nationally, an estimated 1,005 children less than five years of age are hospitalized for Hib meningitis and 5,107 are hospitalized for Hib pneumonia. Among children with Hib meningitis, at least 100 will develop severe neurologic sequelae and 40 will die. These data suggest there is a substantial burden of Hib disease in Vietnam. National leaders will be provided with these data to facilitate development of national vaccination policies for children in Vietnam.


Subject(s)
Haemophilus influenzae type b/growth & development , Meningitis, Haemophilus/epidemiology , Child, Preschool , Female , Humans , Incidence , Infant , Infant, Newborn , Male , Meningitis, Haemophilus/cerebrospinal fluid , Meningitis, Haemophilus/microbiology , Vietnam/epidemiology
11.
Article in Russian | MEDLINE | ID: mdl-16146219

ABSTRACT

In the process the cultivation of H. influenzae, type b, in semisynthetic nutrient medium with aminopeptide base the growth of the bacteria and the synthesis of capsular polysaccharide were shown to depend on the concentrations of aminopeptide, nicotinamide adenine nucleotide (NAD) and hemin. An increase in the concentrations of NAD and hemin stimulated the growth of H. influenzae and inhibited the synthesis of capsular polysaccharide. Similar effect was observed in the simultaneous increase of NAD and hemin concentrations. At elevated concentrations of NAD and hemin and the content of aminopeptide equal to 350 mI/l the maximum weight of biomass was achieved. The increase of hemin concentration had no influence on the growth of H. influenzae, type b, and the synthesis of capsular polysaccharide.


Subject(s)
Haemophilus influenzae type b/growth & development , Haemophilus influenzae type b/metabolism , Polysaccharides, Bacterial/biosynthesis , Bacterial Capsules/metabolism , Culture Media , Hemin , NAD
12.
Article in Russian | MEDLINE | ID: mdl-16028527

ABSTRACT

The influence of the aminopeptide concentration on the growth of H. influenzae b culture and the synthesis of H. influenzae b capsular polysaccharide was determined. The maximum amount of capsular polysaccharide was accumulated at the concentration of aminopeptide in the culture fluid reaching 50 ml/l. An increase in the aminopeptide concentration led to a decreased amount of synthesized polysaccharide and an increased amount of biomass. The decrease of the aminopeptide concentration to 10 ml/l resulted in decreased amounts of both biomass and synthesized polysaccharide.


Subject(s)
Bacterial Capsules/metabolism , Haemophilus influenzae type b/growth & development , Polysaccharides/biosynthesis , Culture Media , Haemophilus influenzae type b/metabolism , Peptides
13.
Rev. ciênc. farm. básica apl ; 26(3): 167-174, 2005.
Article in Portuguese | LILACS | ID: lil-458675

ABSTRACT

As doenças provocadas por cepas de Haemophilus influenzae tipo b (Hib),como por exemplo, conjuntivite, otite média, meningite e pericardite têm apresentado uma sensível diminuição em resposta ao uso da vacina anti Hib no esquema de vacinação nacional.No entanto, com a eliminação da colonização da nasofaringe por Hib, abre-se a possibilidade da substituição de cepas colonizadoras que apresentam este sorotipo capsular por outros sorotipos ou pela colonização por H.influenzae não tipavel (NTHi).Neste sentido, as creches representam um fator de risco para a transmissão das bactérias em função do prolongado e intenso contacto entre as crianças neste ambiente.O objetivo do presente estudo foi apresentar uma revisão atualizada sobre a colonização e transmissão de H.influenzae em crianças saudáveis que freqüentam creches.Concluiu-se que as crianças que freqüentam creches devem ser continuamente monitoradas, para se verificar a eliminação da colonização na nasofaringe por Hib ou a sua substituição por cepas de outros sorotipos ou NTHi.


Subject(s)
Child , Child Day Care Centers , Nasopharyngeal Diseases/epidemiology , Haemophilus influenzae type b/growth & development , Haemophilus Vaccines
14.
J Antimicrob Chemother ; 52(4): 695-8, 2003 Oct.
Article in English | MEDLINE | ID: mdl-12951346

ABSTRACT

OBJECTIVES: A national surveillance study to determine antimicrobial susceptibility in Haemophilus influenzae type b isolated from cerebrospinal fluid was carried out in Cuba from 1990 to 2002. METHODS: Susceptibility to ampicillin, co-amoxiclav, cefotaxime, ceftriaxone, co-trimoxazole, tetracycline, chloramphenicol and rifampicin was tested by the microdilution method according to the NCCLS guidelines. RESULTS: The 34 participating laboratories recovered 938 consecutive, non-identical isolates. All the isolates were retrieved from children aged <5 years. The mean number of isolates collected by year in the pre-vaccination era (1990-1998) was 93; after vaccination, 57 isolates were reported in 1999, 31 in 2000, four in 2001 and five in 2002. Resistance to ampicillin, co-trimoxazole, tetracycline and chloramphenicol was 46.3% (all beta-lactamase-positive), 51.3%, 33.2% and 44.0%, respectively. Ampicillin-resistant beta-lactamase-negative strains were not detected. All strains were susceptible to co-amoxiclav, cefotaxime, ceftriaxone and rifampicin. Ampicillin resistance was strongly associated with resistance to tetracycline, co-trimoxazole and chloramphenicol (P<0.001). Multidrug resistance was present in 43.8% of isolates. The most prevalent phenotype was resistance to ampicillin/chloramphenicol/tetracycline/co-trimoxazole, which was detected in 29.2% of strains overall. An increase in the prevalence of resistance to these antibiotics was observed from 1990 to 2000 in the range 40.7%-54.8% for ampicillin, 40.1%-51.6% for chloramphenicol, 45.4%-58.1% for co-trimoxazole and 23%-45.2% for tetracycline. CONCLUSIONS: In Cuba, the widespread vaccination against Haemophilus influenzae type b prevented a large number of meningitis cases in children caused by strains resistant to multiple antibiotics.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Drug Resistance, Multiple, Bacterial/drug effects , Haemophilus influenzae type b/drug effects , Meningitis, Haemophilus/drug therapy , Anti-Bacterial Agents/pharmacology , Chi-Square Distribution , Child, Preschool , Confidence Intervals , Cuba/epidemiology , Drug Resistance, Multiple, Bacterial/physiology , Haemophilus influenzae type b/growth & development , Humans , Meningitis, Haemophilus/epidemiology , Microbial Sensitivity Tests/methods , Microbial Sensitivity Tests/trends , Odds Ratio
15.
Appl Biochem Biotechnol ; 110(2): 91-100, 2003 Aug.
Article in English | MEDLINE | ID: mdl-14515024

ABSTRACT

Haemophilus influenzae type b (Hib) causes invasive infections in infants and young children. Vaccines consisting of Hib capsular polysaccharide (polymer of ribosylribitol phosphate [PRP]) conjugated to a protein are effective in the prevention of such infections. The production of capsular polysaccharide type b was studied in three cultivation conditions: single, glucose pulse, and repeated batch. Specific polysaccharide production (Yp/x) was calculated for all experiments, showing the following values: 67 (single-batch cultivation), 71 (glucose pulse), 75 (repeated-batch cultivation, first batch), and 87 mg of PRP/g of dry cell weight (DCW) (repeated-batch cultivation, second batch). Biomass concentration reached approximately 1.8 g of DCW/L, while polysaccharide concentration was about approximately 132 mg/L in the three fermentation runs. Polysaccharide synthesis is associated with cell growth in all studied conditions as established by Kono's analysis and Luedeking-Piret's model.


Subject(s)
Haemophilus Infections/metabolism , Haemophilus Vaccines/biosynthesis , Haemophilus influenzae type b/metabolism , Polysaccharides, Bacterial/biosynthesis , Bacterial Capsules , Bacteriological Techniques , Biomass , Bioreactors , Cell Division , Fermentation , Glucose/metabolism , Haemophilus influenzae type b/growth & development , Oxygen/metabolism
16.
Indian J Pediatr ; 70(6): 489-93, 2003 Jun.
Article in English | MEDLINE | ID: mdl-12921318

ABSTRACT

Hib vaccine is the 8th vaccine knocking at the door to be included in the EPI the world over. However there are some controversies that need to be addressed, especially when it comes to use of this vaccine in India. It is difficult to culture Hib unless one uses sheep blood enriched media for culture. There is a lack of good community based data on Hib burden in India. This makes many feel that Hib is rare in India. However this is not true. There are many studies that have looked at this closely. Hib is a common cause of meningitis and pneumonitis in children less than 5 years old in India. There is wide spread problem of multi-drug resistance by Hib in India. Mortality of meningitis is as high as 100% if third generation cephalosporins are not used in time. Of the survivors of meningitis, 60% develop long-term sequelae. Hib vaccine is very effective and can lead to 99% reduction with mass vaccination in just 2-3 years. It is also a very safe vaccine. Of the conjugated vaccines available in India all are equally effective and safe and there is nothing to choose one over the other. There is a need to give a booster dose at 15-18 months of age. Even UK, which never gave the booster dose, is seriously thinking of changing their practice and give a booster dose. Lastly the combination vaccines of Hib with IPV, DPwT/DPaT, and Hepatitis B are safe and effective and should be encouraged to improve the compliance. The use of Hib vaccine is recommended in India, for those who can afford the vaccine.


Subject(s)
Haemophilus Infections/prevention & control , Haemophilus Vaccines/administration & dosage , Haemophilus influenzae type b/isolation & purification , Mass Vaccination , Polysaccharides, Bacterial/administration & dosage , Bacterial Capsules , Child, Preschool , Cost-Benefit Analysis , Dissent and Disputes , Drug Resistance, Bacterial , Haemophilus Infections/economics , Haemophilus Infections/epidemiology , Haemophilus influenzae type b/drug effects , Haemophilus influenzae type b/growth & development , Humans , Immunization, Secondary , India/epidemiology , Infant , Mass Vaccination/economics , Mass Vaccination/methods , Vaccines, Combined/administration & dosage
17.
Infect Immun ; 71(1): 163-72, 2003 Jan.
Article in English | MEDLINE | ID: mdl-12496162

ABSTRACT

Knockout mutations were constructed in the arcA gene of a virulent type b strain of Haemophilus influenzae, and the behavior of the resulting mutants was investigated in a number of conditions that mimicked distinct steps in the natural infection pathway. In arcA mutants, synthesis of capsule and lipooligosaccharide (LOS) and growth in synthetic media were unaltered compared to synthesis of capsule and LOS and growth in synthetic media in the wild-type H. influenzae type b parent strain. However, the virulence of the arcA mutants for BALB/c mice was significantly reduced. Upon exposure to human blood or serum, the arcA mutants showed markedly reduced survival compared with the survival of its wild-type parent. Serum resistance could be fully restored by complementation in cis with the H. influenzae arcA gene but not by complementation in cis with the homologous gene from Escherichia coli. The proteomes of wild-type and mutant bacteria were markedly different, especially under anaerobic conditions, underscoring the global regulatory role of ArcAB in H. influenzae. Evaluation of antibody titers and classical complement activities in various serum samples pointed to complement-mediated bactericidal activity as the factor that distinguishes between the arcA mutant and wild-type phenotypes. Comparative analysis of the membrane fractions of the arcA mutants and the wild-type strain revealed several ArcA-regulated proteins, some of which may be implicated in the serum hypersensitivity phenotype.


Subject(s)
Bacterial Outer Membrane Proteins/metabolism , Bacterial Proteins/metabolism , Blood Bactericidal Activity , Gene Expression Regulation, Bacterial , Haemophilus influenzae type b/pathogenicity , Repressor Proteins , Animals , Bacterial Capsules/metabolism , Bacterial Outer Membrane Proteins/genetics , Bacterial Proteins/genetics , Cell Line , Escherichia coli Proteins , Haemophilus Infections/immunology , Haemophilus Infections/microbiology , Haemophilus influenzae type b/growth & development , Humans , Lipopolysaccharides/metabolism , Male , Mice , Mice, Inbred BALB C , Mutation , Signal Transduction , Virulence
18.
Article in Russian | MEDLINE | ID: mdl-12141040

ABSTRACT

The work shows the possibility of the cultivation of H. influenzae, serotype b, in semisynthetic nutrient medium with amino peptide as the only source of amino acids, glucose--as the main source of carbon and energy and containing, in addition, the necessary growth factors and vitamins.


Subject(s)
Haemophilus influenzae type b/growth & development , Culture Media , Glucose , Growth Substances , Humans , Peptides , Vitamins
19.
Article in Russian | MEDLINE | ID: mdl-12043160

ABSTRACT

The dynamics of H. influenzae, serotype b, growth and synthesis of their capsular polysaccharide in the synthetic nutrient medium, proposed by Herriot for noncapsular strains, was studied using 6 strains. The growth rate of H. influenzae, serotype b, and the amount of capsular polysaccharide, synthesized in the above mentioned medium, practically were not different from those in heart-brain broth (Difco). The possibility of minimizing the composition of Herriot's medium without any adverse effect on the amount of synthesized capsular polysaccharide was shown. As the result of these studies, the expediency of the cultivation of H. influenzae, serotype b, in the synthetic medium, intended for obtaining the preparations of capsular polysaccharide, was proved.


Subject(s)
Haemophilus Vaccines/biosynthesis , Haemophilus influenzae type b/growth & development , Haemophilus influenzae type b/metabolism , Polysaccharides, Bacterial/biosynthesis , Bacterial Capsules , Bacteriological Techniques , Culture Media/chemistry , Kinetics
20.
Article in Russian | MEDLINE | ID: mdl-11550547

ABSTRACT

In many countries vaccination against Haemophilus influenzae of type b (Hib) has permitted the liquidation of severe generalized forms of infections caused by these bacteria. The vaccine is obtained on the basis of Hib capsular polysaccharide. To obtain pure capsular polysaccharide, Hib should be cultivated on synthetic nutrient media. The present review deals with the data substantiating the advantages of using synthetic nutrient media for the cultivation of these bacteria with a view to obtaining pure capsular polysaccharide.


Subject(s)
Haemophilus influenzae type b/growth & development , Haemophilus influenzae type b/metabolism , Bacterial Capsules , Child , Culture Media , Haemophilus Vaccines/biosynthesis , Haemophilus Vaccines/isolation & purification , Humans , Polysaccharides, Bacterial/biosynthesis , Polysaccharides, Bacterial/isolation & purification
SELECTION OF CITATIONS
SEARCH DETAIL